Gelbrane: Combined Gel and Membrane for Robust Western Blotting
Gelbrane: Combined Gel and Membrane for Robust Western Blotting
批准号:
10759072
负责人:
Marc R. Birtwistle
金额:
$29.77万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-08-08 至 2024-08-07
关键词:
AcrylamidesActinsAdsorptionAntibodiesBiological AssayBiologyBiomedical ResearchBloodCapitalCellsChemistryClinicalCollaborationsDataDetectionDiagnosticDropsDrynessElectrophoresisGelGoalsImmunoprecipitationIndustrializationInterventionLegal patentLettersManualsMarketingMembraneMethodsMolecular WeightOutcomePaperPerformancePharmacologic SubstancePhasePlayPolyacrylamide Gel ElectrophoresisPoriferaPost-Translational Protein ProcessingProbabilityProductionProtein AnalysisProteinsProtocols documentationPublicationsPyroxylinReproducibilityResearchResearch PersonnelRestRouteSamplingSignal TransductionSmall Business Technology Transfer ResearchSpeedTechniquesTechnologyTestingThickTimeTissuesTrustVariantWestern BlottingWidthWorkcommercial applicationcostdesignexperimental studyimprovedinnovationinterestmigrationoperationpolyacrylamide gelspolyvinylidene fluoridepre-clinicalresearch and developmentsuccesstechnological innovation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The goal of this Phase I STTR is to develop the gelbrane, a precast polyacrylamide gel combined with a transfer
membrane, and a transfer apparatus. Western blotting, one of the most widely used protein assays in biomedical
research, enables detection of specific proteins and their post-translational modifications in blood, tissue, or cell
lysate samples via molecular weight-based separation. The technique has remained practically identical to when
it was first introduced in the late 1970s, and is often considered a gold standard for protein analysis. Following
separation of lysate proteins by polyacrylamide gel electrophoresis, proteins are transferred onto a PVDF
(polyvinylidene difluoride) or nitrocellulose membrane. A major error-prone step is construction of a “transfer
sandwich”, where a membrane, blotter paper, and sponges are manually arranged around the gel following
electrophoresis. Errors here often result in a completely failed experiment that is only discovered after ~2-3 days,
causing sample loss, increased labor, lost time, and poor reproducibility. Current western blotting methods
mainly rely on immersed vertical electrophoresis, with sample wells traversing the entire gel thickness. In this
arrangement, a membrane already in close contact with a gel would non-specifically adsorb sample, rendering
separation practically useless. There is an unmet need for a product that eliminates the need for manual transfer
sandwich construction, while remaining affordable and familiar to investigators. We will develop two products:
(i) a precast gelbrane cassette that contains a membrane already in perfect contact with a polyacrylamide gel
and is drop-in-ready for electrophoresis and transfer and (ii) a transfer apparatus for the gelbrane cassette that
eliminates manual construction of a transfer sandwich. An enabling innovation is our prior horizontal tank-based
immersed polyacrylamide gel electrophoresis (patent pending); only semi-dry horizontal or immersed vertical
tank exist. This enables us to innovate precast gels by including a PVDF or nitrocellulose membrane during gel
casting, creating the gelbrane, which is “drop-in-ready” for our horizontal electrophoresis and transfer apparati.
Phase I Hypothesis. Can a precast gelbrane cassette reliably undergo sample loading, electrophoresis, and
transfer? We hypothesize that by performing horizontal tank-based immersed electrophoresis, samples will not
come into contact with the membrane prior to transfer, enabling comparable results to gold-standard western
blotting with reduced probability for error. In Aim 1, we will establish robust electrophoresis with the gelbrane
cassette, focusing on 12 well gels and molecular weight ladder. In Aim 2, we will develop a robust gelbrane
transfer apparatus, and use both molecular weight ladder and cell lysates. Success in each aim is defined by
variability (CV%) across analytes and technicians to be ~<10%. We expect to have a beta-testable product at
the end of Phase I. Our market is academic research labs and pre-clinical pharmaceutical R&D labs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Accessible and Robust High-Throughput Western Blotting for Small Sample Sizes
-
批准号:10545990
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2022
-
负责人:Marc R. Birtwistle
-
依托单位:
Mechanistic Pharmacodynamic Modeling for Drug Combination Responses
-
批准号:10398952
-
项目类别:
-
资助金额:$37.23万
-
财政年份:2021
-
负责人:Marc R. Birtwistle
-
依托单位:
Mechanistic Pharmacodynamic Modeling for Drug Combination Responses
-
批准号:10580895
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2021
-
负责人:Marc R. Birtwistle
-
依托单位:
Mechanistic Pharmacodynamic Modeling for Drug Combination Responses
-
批准号:10592423
-
项目类别:
-
资助金额:$37.23万
-
财政年份:2021
-
负责人:Marc R. Birtwistle
-
依托单位:
Mechanistic Pharmacodynamic Modeling for Drug Combination Responses
-
批准号:10206849
-
项目类别:
-
资助金额:$37.23万
-
财政年份:2021
-
负责人:Marc R. Birtwistle
-
依托单位:
Administrative Supplement to Support Summer Undergraduate Research for the Parent MIRA Award R35 GM141891 “Mechanistic Pharmacodynamic Modeling for Drug Combinations"
-
批准号:10809119
-
项目类别:
-
资助金额:$0.99万
-
财政年份:2021
-
负责人:Marc R. Birtwistle
-
依托单位:
Multiplexed, Quantitative Fluorescence Imaging in Tumor Sections
-
批准号:9566479
-
项目类别:
-
资助金额:$19.85万
-
财政年份:2015
-
负责人:Marc R. Birtwistle
-
依托单位:
Multiplexed, Quantitative Fluorescence Imaging in Tumor Sections
-
批准号:9329290
-
项目类别:
-
资助金额:$22.12万
-
财政年份:2015
-
负责人:Marc R. Birtwistle
-
依托单位:
Multiplexed, Quantitative Fluorescence Imaging in Tumor Sections
-
批准号:8928922
-
项目类别:
-
资助金额:$25.81万
-
财政年份:2015
-
负责人:Marc R. Birtwistle
-
依托单位:
Drug Combination Signatures for Prediction and Mitigation of Toxicity
-
批准号:8787833
-
项目类别:
-
资助金额:$209.97万
-
财政年份:2014
-
负责人:Marc R. Birtwistle
-
依托单位:
Predicting the Heterogeneity of Cell-Fate Decisions
-
批准号:9027234
-
项目类别:
-
资助金额:$7.72万
-
财政年份:2014
-
负责人:Marc R. Birtwistle
-
依托单位:
Predicting the Heterogeneity of Cell-Fate Decisions
-
批准号:9199219
-
项目类别:
-
资助金额:$18.86万
-
财政年份:2014
-
负责人:Marc R. Birtwistle
-
依托单位:
Predicting the Heterogeneity of Cell-Fate Decisions
-
批准号:8631470
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2014
-
负责人:Marc R. Birtwistle
-
依托单位:
Predicting the Heterogeneity of Cell-Fate Decisions
-
批准号:8806562
-
项目类别:
-
资助金额:$33.48万
-
财政年份:2014
-
负责人:Marc R. Birtwistle
-
依托单位:
Project 1 (Birtwistle)
-
批准号:8720327
-
项目类别:
-
资助金额:$9.41万
-
财政年份:2007
-
负责人:Marc R. Birtwistle
-
依托单位:
Project 1 (Birtwistle)
-
批准号:8916135
-
项目类别:
-
资助金额:$9.41万
-
财政年份:2007
-
负责人:Marc R. Birtwistle
-
依托单位:
Project 1 (Birtwistle)
-
批准号:8728886
-
项目类别:
-
资助金额:$8.47万
-
财政年份:2007
-
负责人:Marc R. Birtwistle
-
依托单位:
Project 1 (Birtwistle)
-
批准号:9335913
-
项目类别:
-
资助金额:$9.41万
-
财政年份:2007
-
负责人:Marc R. Birtwistle
-
依托单位:
Administrative Core
-
批准号:9540045
-
项目类别:
-
资助金额:$19.81万
-
财政年份:--
-
负责人:Marc R. Birtwistle
-
依托单位:
Data Generation Core
-
批准号:9320878
-
项目类别:
-
资助金额:$92.15万
-
财政年份:--
-
负责人:Marc R. Birtwistle
-
依托单位:
海外基金